CD81 and neoplasm: Furthermore, the kinase reactome analyses identified the phosphoproteome kinase networks shared between CD81 and CD44 regulation, including PAK2, one of our previously identified targets of CD44 in tumor cluster formation (Liu et al., 2019; Figure 2—figure supplement 3A,B, Supplementary file 7).